0002-4312 : Reyvow 50 mg Oral Tablet


NDC: 0002-4312
Labeler: Eli Lilly and Company
Product Type: Human Prescription Drug
Drug Name:  Reyvow
Dosage Form: Oral Tablet
Application #: NDA211280
Rev. Date: 
CSA Schedule: CV (US) [1]


[1] Schedule V Controlled Substance: Low potential for abuse relative to substances listed in Schedule IV and consist primarily of preparations containing limited quantities of certain narcotics. (i.e. Cough preparations containing not more than 200 milligrams of Codeine per 100 milliliters or per 100 grams [such as Robitussin AC, Phenergan with Codeine], and Ezogabine). More Details: US Dept of Justice Controlled Substance Schedules.

Appearance:


Markings: L50;4312
Shapes:  Oval
Colors:  Gray
Size (mm): 9
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

NDC Package Codes:

  • 0002-4312-08: 2 BLISTER PACK IN 1 CARTON (0002‑4312‑08) > 4 TABLET IN 1 BLISTER PACK
  • 0002-4312-61: 1 BLISTER PACK IN 1 CARTON (0002‑4312‑61) > 4 TABLET IN 1 BLISTER PACK
  • 0002-4312-62: 1 BLISTER PACK IN 1 CARTON (0002‑4312‑62) > 2 TABLET IN 1 BLISTER PACK

Active Ingredients:

  • Lasmiditan

Dosage Strength:

  • 50 mg

Inactive Ingredients:

  • Microcrystalline Cellulose
  • Starch, Corn
  • Croscarmellose Sodium
  • Sodium Lauryl Sulfate
  • Magnesium Stearate
  • Polyvinyl Alcohol, Unspecified
  • Titanium Dioxide
  • Polyethylene Glycol 3350
  • Talc
  • Ferrosoferric Oxide /

Related Products:

Based on records with the same trade name.
  • 0002-4491 Reyvow 100 mg Oral Tablet by Eli Lilly and Company
  • 0002-4736 Reyvow 200 mg Oral Tablet by Eli Lilly and Company

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 0002-4312 QR Code

< Prev: 0002-4184Next: 0002-4415 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.